Your browser is no longer supported. Please, upgrade your browser.
Settings
BAX Baxter International Inc. daily Stock Chart
BAX [NYSE]
Baxter International Inc.
IndexS&P 500 P/E5.91 EPS (ttm)9.00 Insider Own0.10% Shs Outstand543.00M Perf Week0.91%
Market Cap28.89B Forward P/E21.74 EPS next Y2.45 Insider Trans-91.61% Shs Float541.41M Perf Month2.29%
Income4.97B PEG0.41 EPS next Q0.52 Inst Own86.10% Short Float1.41% Perf Quarter16.35%
Sales10.16B P/S2.84 EPS this Y10.70% Inst Trans-1.39% Short Ratio2.58 Perf Half Y11.05%
Book/sh15.27 P/B3.48 EPS next Y12.92% ROA30.70% Target Price53.64 Perf Year23.34%
Cash/sh5.16 P/C10.31 EPS next 5Y14.43% ROE57.60% 52W Range41.87 - 53.71 Perf YTD20.31%
Dividend0.52 P/FCF43.32 EPS past 5Y18.40% ROI5.30% 52W High-0.93% Beta0.76
Dividend %0.98% Quick Ratio1.90 Sales past 5Y-6.10% Gross Margin38.60% 52W Low27.07% ATR0.61
Employees48000 Current Ratio2.40 Sales Q/Q1.60% Oper. Margin-11.90% RSI (14)62.52 Volatility0.91% 1.07%
OptionableYes Debt/Eq0.34 EPS Q/Q32.10% Profit Margin48.90% Rel Volume1.50 Prev Close53.45
ShortableYes LT Debt/Eq0.34 EarningsApr 26 BMO Payout5.60% Avg Volume2.97M Price53.21
Recom2.70 SMA201.12% SMA503.26% SMA20011.42% Volume4,407,600 Change-0.45%
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $40 → $47
Apr-14-16Upgrade Piper Jaffray Neutral → Overweight
Feb-03-16Reiterated RBC Capital Mkts Sector Perform $37 → $40
Nov-16-15Resumed Piper Jaffray Neutral $90 → $39
Aug-11-15Reiterated Barclays Overweight $43 → $45
Jul-30-15Downgrade Leerink Partners Outperform → Mkt Perform $82 → $40
Jul-13-15Reiterated RBC Capital Mkts Sector Perform $74 → $37
Jul-02-15Reiterated Barclays Overweight $80 → $43
Jul-02-15Downgrade BofA/Merrill Buy → Neutral
Jul-01-15Downgrade Credit Suisse Outperform → Neutral $75 → $39
Jun-24-15Initiated Goldman Buy
May-19-15Reiterated Barclays Overweight $83 → $80
Jan-08-15Reiterated RBC Capital Mkts Sector Perform $72 → $76
Oct-17-14Reiterated RBC Capital Mkts Sector Perform $78 → $72
Oct-17-14Reiterated Barclays Overweight $88 → $83
Apr-25-17 09:09AM  What to Expect from Baxter Internationals 1Q17 Earnings Market Realist
07:39AM  A Look at Baxter Internationals 1Q17 Revenue Estimates Market Realist
Apr-24-17 05:21PM  Baxter International: What Analysts Recommend ahead of Q1 Results Market Realist
12:47PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baxter International, Inc. - BAX Accesswire
Apr-21-17 10:37AM  Will Baxter International (BAX) Disappoint in Q1 Earnings? Zacks
07:54AM  Baxter Launches Drug Library Guide for Smart Infusion System Zacks
07:20AM  Why Is Baxter International (BAX) Up 5.5% Since the Last Earnings Report? Zacks
Apr-20-17 08:30AM  Baxter Introduces Comprehensive Guide for Building a Smart Infusion System Drug Library Business Wire
Apr-19-17 09:13PM  Pfizer subpoenaed in U.S. intravenous saline solution probe Reuters
04:15PM  Baxter to Present at the UBS Global Healthcare Conference Business Wire
03:05PM  Pfizer subpoenaed in U.S. intravenous saline solution probe Reuters
11:24AM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Baxter International Inc. Business Wire
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Baxter International, Inc. (BAX) PR Newswire
Apr-18-17 04:15PM  Baxter to Present at the Bank of America Merrill Lynch Healthcare Conference Business Wire
Apr-17-17 09:22PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Baxter International Inc. and Advises Investors with Losses to Contact the Firm Business Wire
05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baxter International, Inc. - BAX PR Newswire
04:56PM  Shares of IV saline maker Baxter dip after employee gets subpoena about possible price fixing CNBC
Apr-14-17 03:31PM  Baxter faces federal criminal inquiry into IV saline sales MarketWatch
Apr-10-17 07:00AM  These 4 'Rocket Stocks' Look Ready for Blastoff TheStreet.com
Apr-07-17 03:55PM  ETFs with exposure to Baxter International, Inc. : April 7, 2017 Capital Cube
Apr-04-17 04:22PM  3 Top Medical Instrument Companies to Buy in 2017 Motley Fool
04:22PM  3 Top Medical Instrument Companies to Buy in 2017
10:40AM  Five Stocks For The Smart Contrarian Investor Forbes
10:40AM  Five Stocks For The Smart Contrarian Investor
Apr-03-17 04:15PM  Baxter International Inc. to Host Webcast of Annual Meeting of Stockholders Business Wire
08:30AM  Baxter Unveils Design Enhancements to FLOSEAL and TISSEEL Hemostatic Agents at AORN Meeting Business Wire
Mar-30-17 04:37PM  Moody's: Outlook for US medical products and devices industry remains stable Moody's
04:37PM  Moody's: Outlook for US medical products and devices industry remains stable
Mar-27-17 10:50AM  Alexion Pharma names former Baxalta chief Ludwig Hantson CEO Reuters
10:50AM  Alexion Pharma names former Baxalta chief Ludwig Hantson CEO
Mar-22-17 04:15PM  Baxter International Inc. to Host First Quarter 2017 Financial Results Conference Call for Investors Business Wire
Mar-20-17 10:20AM  Baxter's Chart Is Still Bullish TheStreet.com
10:20AM  Baxter's Chart Is Still Bullish
Mar-15-17 02:05PM  The stock market still isn't accounting for this massive stimulus likely coming from Trump at CNBC
09:00AM  Baxter and the Institute for Safe Medication Practices (ISMP) Address Global Medication Error Prevention Business Wire
Mar-14-17 08:05AM  New Data Indicates Use of Baxters FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs Business Wire
Mar-13-17 04:36PM  U.S. medtech shares gain as investors seek shelter from drug price debate
Mar-09-17 09:15AM  Baxter Celebrates World Kidney Day Business Wire
07:57AM  Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?
Mar-03-17 04:15PM  Baxter to Present at the Barclays Global Healthcare Conference Business Wire
08:32AM  BAXTER INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State
Mar-02-17 01:04PM  BAXTER INTERNATIONAL INC Financials
07:48AM  Baxter Partners ScinoPharm, Expands in Generic Injectables
Mar-01-17 12:24PM  Five Companies to Benefit from Activist Starboard Values Involvement in 2017 at Insider Monkey
Feb-28-17 08:00AM  Baxter and ScinoPharm Announce Exclusive Strategic Partnership for Generic Oncology Injectables Business Wire
Feb-27-17 02:01PM  Baxter International Maintains Its Long-Running Uptrend
Feb-23-17 05:24PM  BAXTER INTERNATIONAL INC Files SEC form 10-K, Annual Report
Feb-21-17 08:30AM  Baxter Declares Quarterly Dividend Business Wire
Feb-16-17 08:30AM  Baxter Debuts Enteral Nutrition ENFit® Syringe and Accessory Line During Clinical Nutrition Week 2017 Business Wire
Feb-11-17 12:01AM  [$$] How to Invest With Ackman and Loeb at Barrons.com
Feb-09-17 04:15PM  Baxter to Present at the 38th Annual Raymond James Institutional Investor Conference Business Wire
Feb-08-17 04:15PM  Baxter to Present at the 37th Annual Cowen and Company Healthcare Conference Business Wire
09:10AM  BAXTER INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State
09:00AM  Baxter Appoints Dr. Stephen Oesterle to Its Board Business Wire
Feb-06-17 01:38PM  ETFs with exposure to Baxter International, Inc. : February 6, 2017
09:58AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 03:31PM  Baxter International Inc Bumps Its Bottom Line at Motley Fool
01:40PM  Baxter International, Inc. :BAX-US: Earnings Analysis: 2016 By the Numbers : February 3, 2017
11:55AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 3, 2017
Feb-02-17 12:45PM  Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary
Feb-01-17 09:27AM  Baxter International (BAX) Q4 Earnings Beat, Revenues Lag
08:43AM  Baxter International (BAX) Q4 Earnings Beat, Sales Miss
08:30AM  Baxter International Inc Earnings Call scheduled for 8:30 am ET today
07:36AM  Baxter beats 4Q profit forecasts
07:13AM  Baxter Reports 2016 Fourth-Quarter and Full-Year Results Business Wire
07:07AM  Q4 2016 Baxter International Inc Earnings Release - Before Market Open
Jan-30-17 12:00AM  Back to zero: Companies use 1970s budget tool to cut costs as they hunt for growth Reuters
Jan-27-17 09:32AM  Will Baxter International (BAX) Disappoint in Q4 Earnings?
Jan-26-17 12:40PM  Baxter International, Inc. : BAX-US: Dividend Analysis : December 02nd, 2016 (record date) : By the numbers : January 26, 2017
Jan-19-17 04:15PM  Baxter to Present at the 6th Annual Leerink Partners Global Healthcare Conference Business Wire
09:15AM  Baxters Renal Therapy Services Significantly Reduced Peritonitis Infections among Home Dialysis Patients Business Wire
Jan-18-17 10:00AM  Spectrum Health Recognized for Excellence in Community Service with 2016 Foster G. McGaw Prize Business Wire
07:49AM  Baxter (BAX): Sluggish Macro Environment Mars Prospects
Jan-12-17 08:37PM  Baxter to pay $18 mln over mold at North Carolina plant Reuters
06:05PM  Baxter Healthcare to pay $18 mln to resolve liability -U.S. Reuters
09:08AM  How Is Mylans Generics Segment Doing?
Jan-11-17 10:26AM  Baxter International, Inc. Value Analysis (NYSE:BAX) : January 11, 2017
08:15AM  Blog Coverage Teleflex's Arrow(R) VPS Rhythm(TM) Device gets FDA Clearance; Launches Laryngeal Mask Accesswire
Jan-10-17 06:15PM  Bill Nygren Comments on Baxter
12:36PM  Bill Nygren's Oakmark Fund Commentary: Fourth Quarter 2016
07:24AM  Baxter International, Inc. breached its 50 day moving average in a Bullish Manner : BAX-US : January 10, 2017
Jan-09-17 09:00AM  New Data Show U.S. Hospital Readmissions are 54 Percent Higher for Malnourished Patients Business Wire
Jan-06-17 04:15PM  Baxter International Inc. to Host Fourth Quarter 2016 Financial Results Conference Call for Investors Business Wire
Dec-30-16 09:34AM  Is Baxter Poised to Counter Low Cyclophosphamide Sales?
Dec-27-16 07:49AM  Boston Scientific Down on Risks; Innovations Raise Hope
Dec-26-16 07:36AM  Financial Metrics of Baxters Acquisition of Claris Injectables
Dec-23-16 12:35PM  How Baxters Acquisition of Claris Injectables Could Boost Growth
11:05AM  Baxter Advances Portfolio with Acquisition of Claris Injectables
09:21AM  What Do Analysts Recommend for Baxter International?
07:32AM  Myriad Genetics: United Rheumatology Selects Vectra DA Test
Dec-22-16 07:59AM  Henry Schein Named 2016's Best Animal Healthcare Provider
Dec-21-16 03:52PM  Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys at Motley Fool
08:35AM  VWR Plagued by Headwinds, Solid Fundamentals Raise Hope
07:49AM  Chemed (CHE): Roto-Rooter Solid, Reimbursement a Concern
Dec-20-16 08:24AM  CVS Health (CVS) Down on Prevailing Risks, Tepid Guidance
07:47AM  Zimmer Biomet (ZBH): Spine Group Solid, Q3 Results a Drag
07:34AM  Align Technology Hits 52-Week High on Q3 & Dental Strength
Dec-19-16 11:40AM  BloodCenter, Versiti name ex-Eli Lilly exec to succeed Jackie Frederick as CEO at bizjournals.com
08:42AM  Bruker (BRKR) Buys Active Spectrum to Boost MRI Business
08:30AM  Hill Rom Gains on Solid Q4, Buyouts & Product Launches
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STROUCKEN ALBERT P LDirectorApr 10Option Exercise30.734,280131,52425,667Apr 12 06:01 PM
STROUCKEN ALBERT P LDirectorApr 10Sale52.804,280225,98421,387Apr 12 06:01 PM
GAVIN JAMES R IIIDirectorMar 29Option Exercise30.734,280131,52434,980Mar 30 04:12 PM
GAVIN JAMES R IIIDirectorMar 29Sale51.724,280221,36230,700Mar 30 04:12 PM
Third Point LLCDirectorFeb 28Sale50.355,901,767297,153,96846,001,790Mar 01 11:25 AM
HELLMAN PETER SDirectorFeb 22Option Exercise30.734,280131,52424,420Feb 23 04:23 PM
HELLMAN PETER SDirectorFeb 22Sale49.814,280213,18720,140Feb 23 04:23 PM
FORSYTH JOHN DDirectorFeb 08Option Exercise30.734,280131,52431,338Feb 10 04:02 PM
FORSYTH JOHN DDirectorFeb 08Sale48.354,280206,93827,058Feb 10 04:02 PM
Shapazian Carole JDirectorFeb 06Option Exercise30.734,280131,52413,507Feb 08 04:14 PM
Shapazian Carole JDirectorFeb 06Sale48.234,280206,4249,227Feb 08 04:14 PM
STORM KORNELIS J.DirectorNov 18Option Exercise30.734,280131,52425,208Nov 22 04:27 PM
STORM KORNELIS J.DirectorNov 18Sale47.104,280201,58820,928Nov 22 04:27 PM
ALMEIDA JOSE EChairman of the Board and CEOMay 23Buy42.7511,691499,79011,691May 24 07:39 AM
FORSYTH JOHN DDirectorMay 02Option Exercise20.961,88739,55226,320May 04 05:46 PM
FORSYTH JOHN DDirectorMay 02Sale44.381,88783,74524,433May 04 05:46 PM